GrandOmics Biosciences Expands Investment in PacBio’s Sequel Systems for Precision Medicine Initiative
MENLO PARK, Calif. and BEIJING, Jan. 04, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that GrandOmics Biosciences Co., Ltd of Beijing, through its subsidiary NextOmics in Wuhan, has agreed to purchase five additional Sequel™ instruments to support China’s precision medicine initiative, with a specific focus on ultimately providing the genetic... Read more